electroCore Inc

Financials

Flujo de caja de las actividades operativas -20.1 M-13.63 M-16.64 M-14.67 M-6.95 M-8.19 M -8.19 M Flujo de caja de las actividades de inversión -7.96 M18.22 M0-206 K-8.52 M3.88 M 3.88 M Flujo de caja de las actividades financieras 18.95 M25.68 M07.49 M8.44 M7.63 M 7.63 M Flujo de caja libre -20.1 M-13.63 M-16.64 M-14.87 M-6.95 M-8.25 M -8.25 M

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

ECOR

Financials

electroCore Inc

Noticias

electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?

electroCore informa sobre estudio de estimulación nerviosa para lesión cerebral

H.C. Wainwright mantiene la recomendación de Compra para electroCore con precio objetivo de 18 dólares

electroCore, Inc. (ECOR) Q4 2025 Earnings Call Transcript

electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates

Electrocore reporta fuerte crecimiento de ingresos en el T4 2025

electroCore reporta un crecimiento de ingresos del 27%, el director ejecutivo se jubilará

MARKER THERAPEUTICS, INC. (MRKR) Reports Q4 Loss, Tops Revenue Estimates

Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for

OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates

electroCore, Inc. (ECOR) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Amneal Pharmaceuticals (AMRX) Q4 Earnings Top Estimates